TREATMENT GUIDE | M22™ Lumenis Description The M22TM is a modular,
multi-application platform featuring Lumenis’ proprietary Optimal Pulse Technology (OPTTM
) and Multiple-Sequential
Pulsing. This innovative and versatile system features a Universal IPL module, Multi-Spot Nd:YAG module, and coming shortly a new fractional non-ablative module, ResurFX. The M22TM
is designed for
performance, consistently producing superior results and predictable treatment outcomes for over 30 applications. M22TM
to attend to your growing practice needs and allows you to grow your patient base with additional applications.
Indications IPL skin treatments, Hair Removal, Pigmented Lesions, Vascular Lesions, Leg Veins, Wrinkles, Striae, Scars,
and more. Availability Worldwide Contact
www.lumenis.com region of the spectrum. The 940 nm
wavelength targets the secondary absorption peak of oxygenated and reduced haemoglobin present in the larger and deeper vessels. For deeper blue veins, the target can be venous blood and it is important to consider the reduced haemoglobin spectrum. Wavelengths that are not strongly absorbed penetrate deeper and can more uniformly heat through larger diameter vessels. As there is less absorption, a much higher fluence (10–15-times greater) must be used with the 940 nm platform. Reduced haemoglobin absorption falls rapidly above 950 nm wavelengths and 940 nm is the longest wavelength for which
offers true flexibility
QX MAX Fotona
Description Combining five laser sources in an advanced, high-powered solution, Fotona’s Q-switched QX MAX laser system effectively removes all common pigmented and certain vascular lesions. The Nd:YAG laser wavelength produces short nanosecond pulses of intense light that pass harmlessly through the top layers of the skin to be selectively absorbed by the melanin pigment in the lesion. The laser light is transformed into photoacoustic waves, which mechanically break up the melanin pigment into smaller particles. These particles are then removed by the body’s own immune system, as the skin’s macro- phages clear the excess
pigment
from the area. Indications Removal of
pigmented and certain
lesions. Contact
www.fotona.com
reduced haemoglobin has adequate absorption. I believe both the 532 nm and 940 nm
MONTH IN PRIME
NEXT Scar removal
To feature your product contact: rosalind.hill@
informa.com
wavelengths are effective for small telangiectasias, but the 940 nm is superior for larger, bluer, and deeper vessels because of its deeper penetration.
Effectiveness I use the 940 nm wavelength almost exclusively at this point owing to its effectiveness with small and large vessels, and rarely use the 532 nm option at all with the exception of using
the computerised scanning device (that accompanies the Varilite system) to treat large areas, which is not compatible with the 940 nm. Although multiple spot size
References
1. Niamtu J. The treatment of vascular and pigmented lesions in oral and maxillofacial surgery. Oral Maxillofacial Surg Clin N Am 2004; 16: 239–54
66 ❚
Figure 2 (A) Before and (B) After treatment with a 940 nm wavelength laser
May/June 2013 |
prime-journal.com
2. Tierney E, Hanke CW. Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser. Lasers Surg Med 2009; 41(8): 555–62
3. Vallee JA, Kelly KM, Rohrer TE, Arndt KA, Dover JS. Lasers in the Treatment of Vascular Lesion. In: Kaminer MS, Arndt KA, Dover JS, Rohrer TS, Zachary CB ed, Atlas of cosmetic surgery. Philadelphia: Saunders Elsevier 2009: 139
handpieces come with the system, I exclusively use the 0.7 mm with the 940 nm for telangiectasias. These wavelengths are representative
of how technology has changed our practices. This small but powerful laser is something I use almost everyday.
Joe Niamtu is Cosmetic Facial Surgeon ,
Fellow of the American Academy of Cosmetic Surgery and the American Society for Lasers in Medicine and Surgery
all common vascular
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76